Labrafil M 2130 Cs

ExcipientUNII 8EPU9MJ01K

1 organisation holds 1 active FDA Type IV Drug Master File for Labrafil M 2130 Cs.

Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity). Methodology

Active Type IV DMFs (1)

HolderDMFFiled asSubmitted
GATTEFOSSE SAS
France
5182LABRAFIL M 2130 CSOct 1983

“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.

What these records establish

  • A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
  • Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
  • The holder is the organisation that filed. It is usually, but not always, the manufacturer.
  • Many excipients are supplied without any DMF, so this list is not every supplier of Labrafil M 2130 Cs.

How to qualify an excipient supplier

For suppliers

Do you supply Labrafil M 2130 Cs?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.